Literature DB >> 34958505

Evolving classification of rhabdomyosarcoma.

Narasimhan P Agaram1.   

Abstract

Rhabdomyosarcomas comprise the single largest category of soft tissue sarcomas in children and adolescents in the United States, occurring in 4.5 million people aged below 20 years. Based on the clinicopathological features and genetic abnormalities identified, rhabdomyosarcomas are classified into embryonal, alveolar, spindle cell/sclerosing and pleomorphic subtypes. Each subtype shows distinctive morphology and has characteristic genetic abnormalities. This review discusses the evolution of the classification of rhabdomyosarcoma to the present day, together with a discussion of key histomorphological and genetic features of each subtype and the diagnostic approach to these tumours.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990FOXO1zzm321990; zzm321990MYOD1zzm321990; alveolar; embryonal; pleomorphic; rhabdomyosarcoma; spindle cell/sclerosing

Mesh:

Substances:

Year:  2022        PMID: 34958505      PMCID: PMC9425116          DOI: 10.1111/his.14449

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   7.778


  56 in total

1.  A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma.

Authors:  A T Gordon; C Brinkschmidt; J Anderson; N Coleman; B Dockhorn-Dworniczak; K Pritchard-Jones; J Shipley
Journal:  Genes Chromosomes Cancer       Date:  2000-06       Impact factor: 5.006

2.  Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

Authors:  Daniel Williamson; Edoardo Missiaglia; Aurélien de Reyniès; Gaëlle Pierron; Benedicte Thuille; Gilles Palenzuela; Khin Thway; Daniel Orbach; Marick Laé; Paul Fréneaux; Kathy Pritchard-Jones; Odile Oberlin; Janet Shipley; Olivier Delattre
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

3.  Diagnosing alveolar rhabdomyosarcoma: morphology must be coupled with fusion confirmation.

Authors:  Leonard H Wexler; Marc Ladanyi
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

4.  Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases.

Authors:  Thomas Mentzel; Cornelius Kuhnen
Journal:  Virchows Arch       Date:  2006-09-30       Impact factor: 4.064

5.  A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.

Authors:  Shinji Kohsaka; Neerav Shukla; Nabahet Ameur; Tatsuo Ito; Charlotte K Y Ng; Lu Wang; Diana Lim; Angela Marchetti; Agnes Viale; Mono Pirun; Nicholas D Socci; Li-Xuan Qin; Raf Sciot; Julia Bridge; Samuel Singer; Paul Meyers; Leonard H Wexler; Frederic G Barr; Snjezana Dogan; Jonathan A Fletcher; Jorge S Reis-Filho; Marc Ladanyi
Journal:  Nat Genet       Date:  2014-05-04       Impact factor: 38.330

6.  Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers.

Authors:  M A Furlong; T Mentzel; J C Fanburg-Smith
Journal:  Mod Pathol       Date:  2001-06       Impact factor: 7.842

7.  In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma.

Authors:  F G Barr; L E Nauta; R J Davis; B W Schäfer; L M Nycum; J A Biegel
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

8.  Spindle cell rhabdomyosarcoma (so-called) in adults: report of two cases with emphasis on differential diagnosis.

Authors:  B P Rubin; R P Hasserjian; S Singer; I Janecka; J A Fletcher; C D Fletcher
Journal:  Am J Surg Pathol       Date:  1998-04       Impact factor: 6.394

9.  Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region. A report of the Intergroup Rhabdomyosarcoma Study.

Authors:  I Leuschner; W A Newton; D Schmidt; N Sachs; L Asmar; A Hamoudi; D Harms; H M Maurer
Journal:  Am J Surg Pathol       Date:  1993-03       Impact factor: 6.394

10.  MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.

Authors:  Narasimhan P Agaram; Michael P LaQuaglia; Rita Alaggio; Lei Zhang; Yumi Fujisawa; Marc Ladanyi; Leonard H Wexler; Cristina R Antonescu
Journal:  Mod Pathol       Date:  2018-09-04       Impact factor: 7.842

View more
  1 in total

1.  Importance of histopathological analysis and molecular genetics in a rare neonatal case of rhabdomyosarcoma.

Authors:  Prudence Gramp; Tania Zappala; Lena Von Schuckmann; Diane Payton; Laura Wheller
Journal:  Australas J Dermatol       Date:  2022-05-02       Impact factor: 2.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.